Skip to content

Understanding Modifications to the Final Rule for 42 CFR Part 2 and How it Affects Your Practice

American Society of Addiction Medicine Logo

The Substance Abuse and Mental Health Services Administration finalized modifications to 42 CFR Part 2, Confidentiality of Substance Use Disorder Records, in February 2024. Join experts from APA and ASAM to learn about the modifications, discuss case studies that apply the modifications, and what to expect over the two-year implementation period.

Register Here


  • Smita Das, M.D., PhD, MPH, is Board Certified in Psychiatry, Addiction Psychiatry and Addiction Medicine. Smita is chair of the APA Council on Addiction Psychiatry and has been a member for a over a decade. Prior to her position as Medical Director of Psychiatry at Lyra Health, Dr. Das was Director of Addiction Treatment Services at the Palo Alto VA. In addition to her work at Lyra, Dr. Das practices in addictions at Stanford School of Medicine where she is a Clinical Associate Professor.
  • Brian Hurley, M.D., MBA, FAPA, DFASAM, is an addiction physician and the Medical Director of the Division of Substance Abuse Prevention and Control for the Los Angeles County Department of Public Health. Brian currently serves as President of the ASAM Board of Directors
  • Carl Erik Fisher, M.D., is an addiction psychiatrist, bioethics scholar, author, and person in recover. He is an assistant professor of clinical psychiatry at Columbia University, where he studies and teaches law, ethics, and policy relating to psychiatry and neuroscience, especially issues related to substance use disorders and other addictive behaviors.

Learning Objectives:

  1. Learn about the modifications to the finalized rule regarding the confidentiality of substance use disorder records.
  2. Apply case studies highlighting modifications to the practice of psychiatry.
  3. Learn about additional resources available to members.

Medical leadership for mind, brain and body.

Join Today